Does γ-hydroxybutyrate inhibit or stimulate central da release?

International Journal of Neuroscience

Volumn 88, Issue 1-2, 1996, Pages 53-69

  Feigenbaum, Jeffery J ^a   Howard, Sherryl G ^b  

^a American Institute of Biotechnology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dopamine release; gamma butyrolactone; Gamma hydroxybutyrate; microdialysis, rat; striatum

Indexed keywords

EID: 0030512461     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.3109/00207459608999812     Document Type: Article

References (96)

1. Abraini, J. H., Raharison, L., & Rostain, J. C. (1991). Long-term depression in striatal dopamine release monitored by in vivo voltammetry in free moving rats. Brain Research, 548, 256-259.
2. Aghajanian, G. K. & Roth, R. H. (1970). γ-hydroxybutyrate-induced increase in dopamine: localization by fluorescence microscopy. Journal of Pharmacology and Experimental Therapeutics, 175, 131-138.
3. Alter, C. A., O'Neil, S. & Marshall, J. F. (1984). Sensorimotor impairment and elevated levels of dopamine metabolites in the neostriatum occur rapidly after intranigral injection of 6-hydroxydopamine or gamma-hydroxybutyrate in awake rats. Neuropharmacology, 23, 309-318.
4. Anden, N.-E., Corrodi, H., Fuxe, K , & Ungerstedt, U. (1971). Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. European Journal of Pharmacology, 15, 193-199.
5. Anden, N.-E., Magnussen, T. & Stock, G. (1973). Effect of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gamma hydroxybutyric acid. Archives of Pharmacology, 278, 363-372.
6. Anden, N-E. & Stock, G. (1973). Inhibitory effect of gamma hydroxybutyric acid and gamma aminobutyric acid on the dopamine cells in the substantia nigra. Naunyn Schmiedeberg Archives of Pharmacol., 279, 89-92.
7. Bettini, E., Ceci, A., Spinelli, R. & Samanin, R. (1987). Neuroleptic-like effects of the I-isomer of fenfluramine on striatal dopamine release in freely moving rats. Biochemical Pharmacol., 36, 2387-2391.
8. Bergstrom, D. A., Bromley, S. D. & Walters, J R. (1984). Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anaesthesia. European Journal of Pharmacol., 100, 3-12.
9. Bessman, S. P. & Fishbein, W. N. (1963). Gamma hydroxybutyrate, a normal brain metabolite. Nature, London, 200, 1207-1208.
10. Brown, E. E., Damsma, G., Cumming, P., & Fibiger, H. C. (1991). Interstitial 3-methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study. Journal of Neurochemistry, 57, 701-707.
11. Bunney, B. S., Walter, J. R., Roth, R. H. & Aghajanian, G K. (1974). Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity. Journal of Pharmacology and Experimental Therapeutics, 185, 560-571.
12. Bustos, G. & Roth, R. H. (1972). Effect of gamma-hydroxybutyrate on the release of monoamines from the rat striatum. British Journal of Pharmacology, 44, 817-820.
13. Carlson, J. H., Bergstrom, D. A., Weick, B. G. & Walters, J. R. (1987). Neurophysiological investigation of the effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Synapse, 1, 411-416.
14. Carroll, B. & Sharp, T. (1972). Mania and hyperactivity induced by morphine in the cat. British Journal of Pharmacology, 46, 124-139.
15. Cheramy, A., Nieoullon, A. & Glowinski, J. (1977). Stimulating effects of gamtna-hydroxybutyrate on dopamine release from the caudate nucleus and the substantia nigra of the cat. Journal of Pharmacology and Experimental Therapeutics, 203, 383-393.
16. Chesselet, M. F., Chermy, A., Reisine, T. D., & Glowinski, J. (1981). Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in the cat caudate nucleus. Nature, 291, 320-322.
17. Chesselet, M. F., Cheramy, A., Reisine, T. D., Lubetzki, C., Glowinski, J., Fournie-Zaluski, M. C., & Roques, B. (1982). Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat. Life Sciences, 31, 2291-2294.
18. Chrapusta, S. J., Karoum, F., Egan, M. F. and Wyatt, R. J. (1992). γ-butyrolactone-sensitive and insensitive dopamine release, and their relationship to dopamine metabolism in three rat brain regions. European Journal of Pharmacology, 222, 129-135.
19. Clemens, J. A. & Phebus, L. A. (1983). Changes in brain chemistry produced by dopaminergic agents: in vivo electrochemical monitoring reveals opposite changes in anaesthetized vs un anaesthetized rats. Brain Research, 267, 183-186.
20. Collin, A.-K , Stahle, L. & Ungerstedt, U. (1988). Effects of halothane anaesthesia on extracellular levels of DA, DOPAC, HVA and 5-HIAA in rat striatum. Acta Physiologies Scandanovean, 132, 30-39.
21. Costa, E. & Garattini, S. (1970). In Amphetamines and releated Compounds, E. Costa & S. Garattini, Eds. New York: Raven Press.
22. Cott, J. & Engel, J (1977). Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: evidence for both pre- and post-synaptic inhibition of catecholamine systems. Journal of Neural Transmission, 40, 253-268.
23. Creese, I. & Iversen, S D. (1975). The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Research, 83, 419-436
24. DeBoer, P , Damsma, G., Fibiger, H C., Timmerman, W., de Vries, J. B. & Westerink, B H. C. (1990). Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis. Naunyn Schmiedeberg's Archives of Pharmacology, 342, 528-534.
25. Dhasmana, K., Dixit, K., Jaja, B., & M. Gupta (1972). Role of central dopaminergic receptors in the manic response of cats to morphine. Psychopharmacology, 24, 380-383.
26. Di Giulio, A. M., Gropetti, A., Cattabeni, F., Galli, C. L., Maggi, A., Algeri, S. & Ponzio, F. (1978). The significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons. European Journal of Pharmacology, 52, 201-207.
27. Doherty, J. D., Hattox, S. E., Snead, O. C. & Roth, R. H. (1978). Identification of endogenous γ-hydroxybutyrate in human and bovine brain and its regional distribution in human, guinea pig and rhesus monkey brain. Journal of Pharmacology and Experimental Therapeutics, 207, 130-139.
28. Dudek, B. C. & Fanelli, R. J. (1980). Effects of gamma-butryolactone, amphetamine and haloperidol in mice differing in sensitivity to alcohol. Psychopharmacology, 68, 89-97.
29. Dyck, L. E. & Kazahoff, C. W. (1982). Acceleration of the biosynthesis of rat striatal dopamine by incubation and by administration of gamma butyrolactone. Journal of Neuroscience Research, 8, 57-65
30. Ellinwood, E. H., Gonzalez, A. E. & Dougherty, G. G. (1983). γ-butyrolactone effects on behavior induced by dopamine agonists Biological Psychiatry, 18, 1023-1032.
31. Feigenbaum, J. J , Yanai, J., & Moon, B. H. (1983). Differential catecholamine uptake inhibition as a possible mode of action of d-amphetamine induced locomotor activity, Research Communications in Chemistry, Pathology and Pharmacology, 39, 349-352.
32. Feldberg, W. & Smyth, D. G. (1976). The C-fragment of lipotropin-a potent analgesic. Journal of Physiology, London, 260, 30-31.
33. Giarman, N. J. (1948). Antibiotic lactones and synthetic analogs, Thesis for the Ph.D. degree, Yale University.
34. Gessa, G. L., Vargiu, L., Crabai, F., Boero, G., Caboni, F., & Camba, R. (1966). Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Science, 5, 1921-1930.
35. Gessa, G. L., Crabai, F., Vargiu, L., & Spano, P. F. (1968). Selective increase of brain dopamine induced by γ-hydroxybutyrate: study of the mechanism of action. Journal of Neurochemistry, 15, 377-381.
36. Gobaille, S., Schmidt, C., Cupo, A., Herbrecht, F. & Maitre, M. (1994). Characterization of methionine-enkephalin release in the rat striatum by in vivo dialysis: effects of gamma-hydroxybutyrate on cellular and extracellular methionine-enkephalin levels. Neuroscience, 60, 637-648.
37. Godschalk, M., Dzoljic, M. & Bonta, I. L (1977). Slow wave sleep and a state resembling absence catalepsy induced by γ-hydroxybutyrate. European Journal of Pharmacology, 44, 105-111.
38. Guidotti, A & Ballotti, P. (1976). Relationship between pharmacologicl effects and blood and brain levels of gamma-butyrolactone and gamma-hydroxybutyrate. Biochemical Pharmacology, 19, 883-894.
39. Hamilton, M. E., Mele, A., & Pert, A. (1992). Striatal extracellular dopamine in conscious vs. anaesthetized rats: effects of chloral hydrate anaesthesic on responses to drugs of different classes Brain Research, 597, 1-7.
40. Hechler, V., Gobaille, S., Bourguignon, J. J., & Maitre, M. (1991). Extracellular events induced by gamma-hydroxybutyrate in striatum. a micordialysis study. Journal of Neurochemistry, 56, 938-944.
41. Hechler, V., Peter, P., Gobaille, S., Bourguignon, J. J., Schmitt, M., Ehrhardt, J. D., Mark, J. & Maitre, M. (1993). γ-hydroxybutyrate ligands possess antidopaminergic and neuroleptic-likle activities, Journal of Pharmacology and Experimental Therapeutics, 264, 1406-1414.
42. Hutchins, D. A., Rayevsky, K. S., & Sharman, D. F. (1972). The effect of sodium γ-hydroxybutyrate on the metabolism of dopamine in the brain. British Journal of Pharmacology, 46, 409-415.
43. Imperato, A. & Di Chiara, G. (1984). Trans-striatal dialysis coupled to reverse phase high performance chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. Journal of Neuroscience, 4, 966-977.
44. Imperato, A. & Di Chiara, G. (1985). Dopamine release and metabolism in awake animals after systemic neuroleptics as studied by trans-striatal dialysis. Journal of Neuroscience, 5, 297-306.
45. Imperato, A. & Di Chiara, G. (1986). Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. Journal of Pharmacology and Experimental Therapeutics, 239, 219-228.
46. Imperato, A., Mulas, A. & Di Chiara, G. (1987). The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. European Journal of Pharmacology, 142, 177-181.
47. Jouany, J. M., Gerard, J., Broussollo, B., Reynier, M., Simone, R., Orsetti, A., Vermuth, C , & Baron, C. (1960). Pharmacologie comparee des sels d'acide butyrique et de l'acide 4-hydroxybutyrique. Agressologie, 1, 417-427.
48. Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., & Atack, C. (1972). Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. Journal of Pharmacy and Pharmacology, 24, 744-747.
49. Kelland, M. D., Freeman, A. S. & Chiodo, L. A. (1989). Chloral hydrate anaesthesia alters the responsiveness of identified midbrain neurons to dopamine agonist administration. Synapse, 3, 30-37.
50. Laborit, H., Jouany, J. M., Gerard, J., & Fabiani, F. (1960). Généralités concernant l'étude expérimentale de l'emploi clinique du gamma hydroxybutyrate de Na Agressologie, 1, 407-411.
51. Lane, R. F. & Blaha, C. D. (1987). Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: demonstration by in vivo electrochemistry. Brain Research, 408, 317-320.
52. Maitre, M , Hechler, V., Vayer, P., Gobaille, S., Cash, C. D., Schmitt, M , & Bourguignon, J.-J. (1990). A specific γ-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. Journal of Pharmacology and Experimental Therapeutics, 255, 657-663.
53. Mamelak, M. (1989) Gammahydroxybutyrate: An endogenous regulator of energy metabolism Neuroscience Behavioral Review, 13, 187-198.
54. McCown, T. J., Mueller, R. A. & Breese, G. R. (1983). Effects of anaesthetics and electrical stimulation on nigrostriatal dopaminergic neurons. Journal of Pharmacology and Experimental Therapeutics, 224, 489-493.
55. Menon, K., Bieger, D., & Hornykiewicz, O. (1976). Pharmacological evidence for a selective anti-dopaminergic action of gamma-hydroxybutyric acid. Journal of Neural Transmission, 39, 177-186.
56. Menon, M., Clark, W., Schindler, A. & Alcarez, A. A (1973) Studies on the mechanism of the akinetic effects of g-hydroxybutyric acid and 1,4-butanediol. Archives Internationales de Pharmacodynamie et de Therapie, 203, 232-242.
57. Moghaddam, B. & Bunney, B. S. (1989). Ionic composition of microdialysis perfusing solution alters the pharmacological responsiveness and basal outflow of striatal dopamine. Journal of Neurochemistry, 53, 652-654.
58. Morganroth, V. H., Walters, J. R., & Roth, R. H. (1976). Dopaminergic neurons. Alterations in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. Biochemical Pharmacology, 25, 655-661.
59. Nielsen, J. A. & Moore, K. E. (1982). Effects of chloral hydrate, gamma-butyrolactone, and equithesin on the efflux of dopamine and 5-hydroxytryptamine metabolites into cerebroventricular perfusates of rats. Journal of Neurochemistry, 39, 235-238.
60. 3H) tyrosine in the cat caudate nucleus: effects of various physical and pharmacological treatments. Journal of Neurochemistry, 28, 819-828.
61. Nissbrandt, H., Elverfors, A. & Engberg, G. (1994). Pharmacologically induced cessation of burst activity in nigral dopamine neurons: Significance for the terminal dopamine efflux. Synapse, 17, 217-224.
62. Osborne, P. G., O'Connor, W. T., Drew, K. L. & Ungerstedt, U (in press). An in vivo characterization of extracellular dopamine and GABA in the dorsolateral striatum of awake, moving, and halothane anaesthetized rats. Journal of Neuoscience Methods.
63. Okuyama, S., Shimamura, H., Hashimoto, S. & Aihara, H. (1986). Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats. Archives Internationales de Pharmacodynamie et de Therapie, 284, 246-254.
64. Pericic, D. and Walters, J. R. (1976). Dopamine in substantia nigra and cortex after γ-butyrolactone treatment. Journal of ???Pharm. Pharmacology., 28, 527-529.
65. Roffler-Tarlov, S., Sharman, D. F. & Tegerdine, P. (1971). 3,4-dihydroxyphenylacetic acid and 4-hydroxy-3-methoxy-phenylacetic acid in the mouse striatum: a reflection of intra- and extra-neuronal metabolism of dopamine? British Journal of Pharmacology, 42, 343-35.
66. Roth, R. H. (1971). Effect of anaesthetic doses of gamma-hydroxybutyrate on subcortical concentrations of homovanillic acid. European Journal of Pharmacology, 15, 52-59.
67. Roth, R. H. (1972). Striatal dopamine and gamma-hydroxybutyrate. In International Encyclopedia of Pharmacology and Therapeutics, Section 35, Oxford: Pergammon Press.
68. Roth, R. H. (1976). Striatal dopamine and gamma-hydroxybutyrate. Pharmacology and Therapeutics, 2, 71-88
69. Roth, R. H., Doherty, J. D. & Walters, J. R. (1980). Gamma-hydroxybutyrate: A role in the regulation of dopaminergic neurons? Brain Research, 189, 556-560.
70. Roth, R. H. & Giarman, N. J. (1970). Natural occurence of gamma -hydroxybutyrate in mammalian brain. Biochemical Pharmacology, 19, 1087-1094.
71. Roth, R. H. & Suhr, Y. (1970). Mechanism of γ -hydroxybutyrate-induced increase in brain dopamine and its relationship to "sleep." Biochemical Pharmacology, 19, 3001-3012.
72. Roth, R. H., Walters, J. R. & Aghajanian, G. K. (1973). Effect of impulse flow on the release and synthesis of dopamine in rat striatum. In Frontiers in catecholamine research, pp. 567-574. E. Usdin & S. Synder, Eds. New York: Pergammon Press.
73. Rubin, B. & Giarman, N. J. (1947) γ-butyrolactone, Yale Journal of Biology and Medicine, 19, 1017-1023.
74. Santiago, M. & Westerink, B. H. (1991). Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. Journal of Neurochemistry, 57, 738-747.
75. Saratikov, A. S., Zamoshchina, T. A., Alekseeva, L. P. & Agarkova, V. P. (1982). Influence of hydroxy-butyrate on the electroencephalographic effects of fenamin, Bulletin of Experimental Biology and Medicine, 94, 46-49.
76. Savaki, H. E., Girault, J.-A., Spampinato, U., Truong, N.-A., Glowinski, J., & Besson, M.-J., (1986). Release of newly synthesized 3H-dopamine in the striatum: An adaptation of the push-pull cannula method to awake restrained and anesthestized rats. Brain Research Bulletin, 16, 149-154.
77. Snead, O. C. (1978). Gamma-hydroxybutyrate in the monkey. I: Electroencephalographic, behavioral and pharmacokinetic studies. Neurology, 28, 636-642.
78. 3H] dopamine release in anaesthetized, awake, restrained and freely moving animals. Brain Research Bulletin, 16, 1161-1166.
79. Spano, P. F., Tagliamonte, A., Tagliamonte, P. & Gessa, G. L. (1971). Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate. Journal of Neurochemistry, 18, 1831-1836.
80. Stahle, L., Collin, A.-K., & Ungerstedt, U. (1990). Effect of halothane anaesthesia on extracellular levels of dopamine, dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxy-indoleacetic acid in rat striatum: a microdialysis study. Naunyn Schmiedeberg Archives of Pharmacology, 342, 136-140.
81. Stock, G., Magnusson, T. & Anden, N. E. (1973). Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedeberg's Archives of Pharmacology, 278, 347-361.
82. Timmerman, W. & Westerink, B. H. C. (1991). Importance of the calcium content infused during microdialysis for the effects induced by D-2 agonists on the release of dopamine in the striatum of the rat. Neuroscience Letters, 131, 93-96.
83. Tolpyschev, B. A. (1980). Influence of GABA-ergic substances on the effects of caudate nucleus stimulation and fenamin stereotyping in cats. Pharmacology and Toxicology, 43, 140-144.
84. Van Valkenburg, C. F. M., Noach, E. L., & Wijling, A. (1979). Involvement of the nerve impulse flow in the release of extragranular dopamine. European Journal of Pharmacology, 57, 191-197.
85. Veyer, P., Mandel, P. & Maitre, M. (1987). γ-Hydroxylate. A possible neurotransmitter. Life Science, 41, 1547-1557.
86. Walters, J. R. & Roth, R. H. (1972). Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochemical Pharmacology, 31, 2111-2121.
87. Walters, J. R. & Roth, R. H. (1974). Dopaminergic neurons: Drug induced antagonisms of the increase in tyrosine hydroxylase activity produced by a cessation of impulse flow. Journal of Pharmacology and Experimental Therapeutics, 191, 82-91.
88. Walters, J. R. & Roth, R. H. (1976). Gammahydroxybutyrate: Considerations of endogenous role and therapeutic potential. In pp. 403-415 E. Usdin & E. Costa, Neuroregulators and Psychiatric Disorders, (Eds.) New York: Oxford University Press.
89. Walters, J. R., Roth, R. H. & Aghajanian, G. K. (1973). Dopaminergic neurons: similar biochemical and histochemical effects of g-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. Journal of Pharmacology and Experimental Therapeutics, 186, 630-339.
90. Westerink, H. C. (1979). Effects of drugs on the formation of 3-methoxytyramine, a dopamine metabolite, in the substantia nigra, striatum, nucleus accumbens and tuberculum olfactorium of the rat. Journal of Pharmacology and Pharmacology, 31, 94-99.
91. Westerink, B. H. C., Hofsteede, H. M., Damsma, G. & de Vries, J B. (1988). The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by microdialysis. Naunyn Schmiedeberg's Archives of Pharmacology, 337, 373-378.
92. Westerink, B. H. C. & Spaan, S J. (1982). On the significance of endogenous 3-methoxytyramine for the effects of centrally acting drugs on dopamine release in the rat brain. Journal of Neurochemistry, 38, 680-686.
93. Wolfson, L. I., Sakurada, O. & Sokoloff, L. (1977). Effects of γ-butyrolactone on local cerebral glucose utilization in the rat. Journal of Neurochemistry, 29, 777-783.
94. Wood, P L., Alter, C. A. & Kim, H. S. (1988). Presynaptic inhibition of nigrostriatal dopamine release in the mouse: lack of cross tolerance between apomorphine, GBL and CGS 107468. Life Science, 42, 1503-1506.
95. Zhang, W. Q., Tilson, H A., Nanry, K. P., Hudson, P. M., Hong, J. S., & Stachowiak, M. K. (1988). Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage Brain Research, 461, 335-342.
96. Zhang, W. Q., Tilson, H. A., Stachowiak, M. K. & Hong, J. S. (1989). Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge. Brain Research, 484, 389-392.